The post Iran Crypto Volume Hits $7.78B as IRGC Controls Half of Market appeared on BitcoinEthereumNews.com. Darius Baruo Jan 15, 2026 15:54 Chainalysis dataThe post Iran Crypto Volume Hits $7.78B as IRGC Controls Half of Market appeared on BitcoinEthereumNews.com. Darius Baruo Jan 15, 2026 15:54 Chainalysis data

Iran Crypto Volume Hits $7.78B as IRGC Controls Half of Market



Darius Baruo
Jan 15, 2026 15:54

Chainalysis data shows Iran’s crypto ecosystem reached $7.78B in 2025, with IRGC-linked addresses controlling 50% of activity. Bitcoin withdrawals surge during protests.

Iran’s cryptocurrency ecosystem swelled to $7.78 billion in 2025, with the Islamic Revolutionary Guard Corps now controlling roughly half of all on-chain activity, according to new blockchain intelligence from Chainalysis. The data paints a picture of crypto serving dual purposes: a sanctions evasion tool for the regime and a financial escape hatch for ordinary citizens watching their currency collapse.

IRGC Tightens Grip on Crypto Flows

The numbers are stark. IRGC-associated wallet addresses received over $3 billion in 2025, up from $2 billion the prior year. By Q4 2025, these addresses represented more than 50% of Iran’s total crypto volume—a steady climb that mirrors the paramilitary organization’s expanding stranglehold on the broader Iranian economy.

These figures likely undercount the true scope. Chainalysis notes they only include addresses identified through OFAC sanctions designations and Israel’s counter-terror financing bureau. Shell companies, unidentified facilitators, and laundering networks remain unmapped. Earlier this month, a separate report found the IRGC moved $1 billion through UK-registered crypto exchanges alone.

The IRGC’s crypto operations extend well beyond Iran’s borders. Linked addresses facilitate commodity transfers, illicit oil sales, arms shipments to proxy militias across the Middle East, and systematic sanctions evasion through what Treasury designated in September 2025 as an “Iranian shadow crypto banking network.”

Crypto Activity Spikes With Conflict

Chainalysis identified clear correlations between major political events and surges in on-chain activity. The Kerman bombings in January 2024, which killed nearly 100 people, triggered one spike. Iran’s October 2024 missile strikes against Israel following the assassinations of Hamas and Hezbollah leaders prompted another.

The June 2025 “12-day war” proved particularly revealing. Joint U.S.-Israeli strikes against Iran’s nuclear and missile programs coincided with cyberattacks on Nobitex, Iran’s largest crypto exchange, and Bank Sepah, a major IRGC banking channel. Hackers breached Iranian state TV to broadcast footage of women’s protests.

Bitcoin as Escape Route

The most telling behavioral shift emerged during mass protests that erupted in late December 2025. Comparing the pre-protest period (November 1 to December 27) with the protest window (December 28 to January 8, when the regime imposed a blanket internet blackout), Chainalysis observed significant increases in both transaction volumes and transfers to personal wallets.

Withdrawals from Iranian exchanges to unattributed personal Bitcoin wallets surged. With the rial having lost approximately 90% of its value since 2018 and inflation running 40-50%, Iranians aren’t just hedging—they’re exiting a collapsing monetary system entirely.

BTC’s appeal goes beyond capital preservation. Its censorship-resistant, self-custodial nature offers something traditional assets can’t: the ability to move wealth outside government-controlled channels. For those who might need to flee, that optionality matters.

What Comes Next

The dual-use nature of crypto in Iran creates a regulatory puzzle with no clean answers. Sanctions pressure will likely intensify IRGC reliance on digital assets for financing operations, while economic deterioration pushes more ordinary Iranians toward the same technology. Chainalysis expects IRGC-linked wallet identification to expand as more of the laundering infrastructure gets exposed through ongoing Treasury and Israeli designations.

For now, blockchain data offers something rare: real-time visibility into how economic stress and political instability reshape financial behavior in closed societies.

Image source: Shutterstock

Source: https://blockchain.news/news/iran-crypto-volume-irgc-dominance-2025

Market Opportunity
Major Logo
Major Price(MAJOR)
$0.13422
$0.13422$0.13422
+3.90%
USD
Major (MAJOR) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

BullZilla, World Liberty Financial, MoonBull, La Culex, and Polkadot (DOT) are taking the spotlight among emerging and established crypto projects […] The post 5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale appeared first on Coindoo.
Share
Coindoo2025/10/18 08:15
Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26